MarkEdwinZafereoJr.MDFACS
Otolaryngology (ENT) • Houston, TXHead & Neck Oncologic Surgery
MD Anderson Cancer Center
Dr. Zafereo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd Unit 1445
Md Anderson Cancer Center Dept Head And Neck Surgery
Houston, TX 77030Phone+1 713-792-6525- Is this information wrong?
Summary
- Dr. Mark Zafereo is an Associate Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas. He is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Endocrine Center at MD Anderson Cancer Center. Dr. Zafereo holds national committee appointments for the American Head and Neck Society, American Academy of Otolaryngology-Head and Neck Surgery, and American Thyroid Association, and American College of Surgeons, and he is a Past President of the Houston Society of Otolaryngology-Head and Neck Surgery. He has published extensively on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients afflicted with thyroid cancer and parathyroid neoplasms.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Otolaryngology - Head and Neck Surgery, 2010 - 2011
Baylor College of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2007 - 2010- University of Texas Health Science Center at HoustonResidency, Otolaryngology - Head and Neck Surgery, 2005 - 2007
- University of Texas Health Science Center at HoustonInternship, Transitional Year, 2005 - 2006
McGovern Medical School at UTHealthClass of 2005
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
TX State Medical License 2010 - 2025
GA State Medical License 2023 - 2025
AL State Medical License 2023 - 2024- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
- Join now to see all
Clinical Trials
- Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer Start of enrollment: 2021 Jun 24
- Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer Start of enrollment: 2021 Feb 26
Publications & Presentations
PubMed
- Recovery of Recurrent Laryngeal Nerve Function With Neoadjuvant Treatment: Neural Characterization.Russell, M., Abdelhamid Ahmed, A., Shonka, D., Siddiqui, S., Athni, T., Park, J., Wirth, L., Feng, Z., Karcioglu, A., Iwata, A., Kyriazidis, N., Zafereo, M., Randolph, G.> ;The Laryngoscope. 2024 Jan 24
- 4 citationsFactors predicting pharyngocutaneous fistula in patients after salvage laryngectomy for laryngeal malignancy - A multicenter collaborative cohort study.Conall W R Fitzgerald, Joel C Davies, John R de Almeida, Jason T Rich, Mario Orsini, Antoine Eskander, Eric Monteiro, Ximena Mimica, Tim Mclean, Jennifer R Cracchiolo,...> ;Oral Oncology. 2022 Nov 1
- 6 citationsOutcomes for recurrent oral cavity squamous cell carcinoma.Kevin J Contrera, Mark E Zafereo, Dan Yaniv, Diane B Roberts, Ann M Gillenwater, Ehab Y Hanna, Randal S Weber, Jeffrey N Myers, Edward I Chang, Patrick B Garvey, Matth...> ;Oral Oncology. 2022 Nov 1
- Join now to see all
Journal Articles
- International Neural Monitoring Study Group Guideline 2018 Part I: Staging Bilateral Thyroid Surgery with Monitoring Loss of SignalGregory W Randolph, Gayle Woodson, Mark Zafereo, Whitney Liddy, Peter Angelos, Lisa Orloff, Louise Davies, Jennifer J Shin, Joseph Scharpf, Richard J Wong, Emad Kandil..., The Laryngoscope
- Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive IodineThinh Vu, Naifa L Busaidy, Maria E Cabanillas, Steven G Waguespack, Steven I Sherman, Mark Zafereo, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
His Thyroid Cancer Was Too Rare for Doctors to Treat. After a Trial, Woodlands Man Now Cancer-FreeDecember 14th, 2022
Thyroid Cancer Survivor: MD Anderson Took Me from Hospice to HopeJanuary 22nd, 2019- Second Opinion, Thyroid Cancer Surgery Finally Put Survivor in RemissionAugust 23rd, 2018
Professional Memberships
- Member
- Fellow
- Member
- Fellow
- American Head and Neck SocietyMember
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
